Title Engineering human rhinovirus serotype-A1 as a vaccine vector.
Author Tomusange, Khamis; Yu, Wenbo; Suhrbier, Andreas; Wijesundara, Danushka; Grubor-Bauk, Branka; Gowans, Eric J
Journal Virus Res Publication Year/Month 2015-May
PMID 25869880 PMCID -N/A-
Affiliation + expend 1.Virology Laboratory, Basil Hetzel Institute, Discipline of Surgery, University of Adelaide, Adelaide, South Australia, Australia.

Herein we describe the construction of recombinant human rhinoviruses (rHRVs) encoding HIV Gag or Tat by inserting the full length tat gene or regions of the gag gene flanked by sequences encoding the HRV 2A protease cleavage site into the junction between HRV genes encoding structural (P1) and non-structural (P2) proteins. Most recombinants were unstable, but this was corrected by mutation of the flanking cleavage sites. Thereafter, all rHRV constructs retained the inserts throughout six passages. Such constructs may find utility as vaccine vectors to generate mucosal immunity.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.